Clinical Trial Update: Omitting of Lymphadenectomy is Acceptable for Lung Cancer Smaller Than 6 mm in Solid Size

View source ↗

Summary

The completed trial evaluated whether omitting lymphadenectomy is feasible and safe for very small non-small cell lung cancers with solid size under 6 mm.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Liang Chen | Conditions: Non-small Cell Lung Cancer | Status: COMPLETED